ARTICLE | Strategy
Good news for dealmakers
$14B consumer health sale gives Merck firepower to expand BD&L deals
May 12, 2014 7:00 AM UTC
While Merck & Co. Inc. continues its stepwise downsizing, the pharma is sending signals that the welcome mat is out for BD&L deals.
The pharma made good on its plan to seek alternatives for its consumer health business with last week's sale of the unit to Bayer AG for $14.2 billion...